Together, these results suggested that overexpression of LPA2 is sufficient to promote IEC proliferation in the colon, but LPA2 overexpression results in dysplasia and inhibits proliferation of IECs in the small intestine. The gene discussed is LPAR2; the disease is dysplasia.